Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease by Joan G. Tell, Beth-Ann G. Coller, Sheri A. Dubey, Ursula Jenal, William Lapps, Liman Wang, Jayanthi Wolf

Get full text

Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach by Bhargava Kandala, Nele Plock, Akshita Chawla, Anna Largajolli, Seth Robey, Kenny Watson, Raj Thatavarti, Sheri A. Dubey, S.Y. Amy Cheung, Rik de Greef, Julie Stone, Jeffrey R. Sachs

Get full text

Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study. by Fusheng Li, Adam C Finnefrock, Sheri A Dubey, Bette T M Korber, James Szinger, Suzanne Cole, M Juliana McElrath, John W Shiver, Danilo R Casimiro, Lawrence Corey, Steven G Self

Get full text

Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP <i>Zaire ebolavirus</i> Vaccine to Inform Marburg Virus and <i>Sudan ebolavirus</i> Vaccines by Beth-Ann G. Coller, William Lapps, Mahum Yunus, Samantha Bruno, Michael J. Eichberg, Andrew Wen-Tseng Lee, Kenneth Liu, Rosybel Drury, Jules Millogo, Louis Robert Macareo, Thomas H. Armstrong, Jeffrey T. Blue, Lynne A. Isopi, Melissa Hughes, Susan M. VanRheenen, Jonathan Deutsch, Joan G. Tell, Sheri A. Dubey

Get full text